187 related articles for article (PubMed ID: 31532272)
1. L1CAM expression in colorectal cancer identifies a high-risk group of patients with dismal prognosis already in early-stage disease.
Tampakis A; Tampaki EC; Nonni A; Tsourouflis G; Posabella A; Patsouris E; Kontzoglou K; von Flüe M; Nikiteas N; Kouraklis G
Acta Oncol; 2020 Jan; 59(1):55-59. PubMed ID: 31532272
[No Abstract] [Full Text] [Related]
2. MAP17 Expression in Colorectal Cancer Is a Prognostic Factor for Disease Recurrence and Dismal Prognosis Already in Early Stage Disease.
Tampakis A; Tampaki EC; Nonni A; Kontos M; Tsourouflis G; Posabella A; Fourie L; Bolli M; Kouraklis G; von Flüe M; Felekouras E; Nikiteas N
Oncology; 2021; 99(7):471-482. PubMed ID: 33853080
[TBL] [Abstract][Full Text] [Related]
3. High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality.
Tampakis A; Tampaki EC; Nonni A; Kostakis ID; Posabella A; Kontzoglou K; von Flüe M; Felekouras E; Kouraklis G; Nikiteas N
BMC Cancer; 2021 Feb; 21(1):153. PubMed ID: 33579217
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas.
Trietsch MD; Oonk MH; Hawinkels LJ; Bor R; van Eendenburg JD; Ivanova Z; Peters AA; Nijman HW; Gaarenstroom KN; Bosse T
Oncotarget; 2016 May; 7(18):26192-205. PubMed ID: 27028855
[TBL] [Abstract][Full Text] [Related]
5. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
Bosse T; Nout RA; Stelloo E; Dreef E; Nijman HW; Jürgenliemk-Schulz IM; Jobsen JJ; Creutzberg CL; Smit VT
Eur J Cancer; 2014 Oct; 50(15):2602-10. PubMed ID: 25126672
[TBL] [Abstract][Full Text] [Related]
6. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients.
Wang YY; Li L; Zhao ZS; Wang YX; Ye ZY; Tao HQ
J Exp Clin Cancer Res; 2013 Sep; 32(1):66. PubMed ID: 24422715
[TBL] [Abstract][Full Text] [Related]
7. Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?
Tampakis A; Tampaki EC; Nonni A; Droeser R; Posabella A; Tsourouflis G; Kontzoglou K; Patsouris E; von Flüe M; Kouraklis G
Oncology; 2019; 96(6):318-325. PubMed ID: 30917374
[TBL] [Abstract][Full Text] [Related]
8. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.
Zhang J; Yang F; Ding Y; Zhen L; Han X; Jiao F; Tang J
Int J Clin Exp Pathol; 2015; 8(8):9240-7. PubMed ID: 26464672
[TBL] [Abstract][Full Text] [Related]
10. L1CAM as a prognostic marker in stage I endometrial cancer: a validation study.
Smogeli E; Davidson B; Cvancarova M; Holth A; Katz B; Risberg B; Kristensen G; Lindemann K
BMC Cancer; 2016 Aug; 16():596. PubMed ID: 27488577
[TBL] [Abstract][Full Text] [Related]
11. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
12. L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB.
Klat J; Mladenka A; Dvorackova J; Bajsova S; Simetka O
Anticancer Res; 2019 Jan; 39(1):421-424. PubMed ID: 30591489
[TBL] [Abstract][Full Text] [Related]
13. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
van der Putten LJM; Visser NCM; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Werner HMJ; Amant F; Massuger LFAG; Pijnenborg JMA
Int J Gynecol Cancer; 2018 Mar; 28(3):514-523. PubMed ID: 29324536
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.
Abdel Azim S; Duggan-Peer M; Sprung S; Reimer D; Fiegl H; Soleiman A; Marth C; Zeimet AG
Oncotarget; 2016 Jun; 7(24):37205-37214. PubMed ID: 27174921
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic potential of β-catenin and L1CAM expression according to endometrial cancer risk group.
Yoon H; Suh DH; Kim K; No JH; Kim YB; Kim H
Gynecol Oncol; 2024 May; 184():132-138. PubMed ID: 38309030
[TBL] [Abstract][Full Text] [Related]
17. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
[No Abstract] [Full Text] [Related]
18. DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer.
Kato K; Maesawa C; Itabashi T; Fujisawa K; Otsuka K; Kanno S; Tada H; Tatemichi Y; Kotani K; Oikawa H; Sugai T; Wakabayashi G; Masuda T
Int J Oncol; 2009 Sep; 35(3):467-76. PubMed ID: 19639167
[TBL] [Abstract][Full Text] [Related]
19. L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer.
Romanová M; Židlík V; Javůrková V; Kondé A; Šimetka O; Klát J
In Vivo; 2023; 37(5):2334-2339. PubMed ID: 37652517
[TBL] [Abstract][Full Text] [Related]
20. p53, Pirh2, and L1CAM as Promising Prognostic Biomarkers of Endometrial Carcinoma: An Immunohistochemical and Genetic Study.
Abdelrahman AE; Salem A; Al Attar AZ; Elsebai E; Samy W; Ibrahim MA; Ibrahim HM
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):713-725. PubMed ID: 36251972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
